Roger Santimaria

发表

Protein quality control: the who’s who, the where’s and therapeutic escapes

J. Roth, V. Le Fourn, C. Zuber, 2007, Histochemistry and Cell Biology.

Basal autophagy is involved in the degradation of the ERAD component EDEM1

J. Roth, V. Le Fourn, C. Zuber, 2009, Cellular and Molecular Life Sciences.

Protein N-glycosylation, protein folding, and protein quality control

J. Cho, I. Jang, J. Roth, 2010, Molecules and cells.

EDEM1 reveals a quality control vesicular transport pathway out of the endoplasmic reticulum not involving the COPII exit sites

D. Hebert, J. Roth, C. Zuber, 2007, Proceedings of the National Academy of Sciences.

Relevance of periostin splice variants in renal cell carcinoma.

G. Kristiansen, H. Moch, P. Schraml, 2011, The American journal of pathology.

Bispecific CD3/HER2 Targeting FynomAb Induces Redirected T Cell-Mediated Cytolysis with High Potency and Enhanced Tumor Selectivity

S. Brack, Ulrich Wuellner, J. Bertschinger, 2015 .

COVA4231, a potent CD3/CD33 bispecific FynomAb with IgG-like pharmacokinetics for the treatment of acute myeloid leukemia

S. Brack, R. Hepler, R. Walter, 2018, Leukemia.

Induced Prion Protein Controls Immune-Activated Retroviruses in the Mouse Spleen

R. Zinkernagel, P. Schwarz, J. Böni, 2007, PloS one.

Discovery and characterization of COVA322, a clinical-stage bispecific TNF/IL-17A inhibitor for the treatment of inflammatory diseases

Sarah Batey, J. Bertschinger, D. Grabulovski, 2015, mAbs.